scholarly journals Insulin Sensitizers May Attenuate Lean Mass Loss in Older Men With Diabetes

Diabetes Care ◽  
2011 ◽  
Vol 34 (11) ◽  
pp. 2381-2386 ◽  
Author(s):  
Christine G. Lee ◽  
Edward J. Boyko ◽  
Elizabeth Barrett-Connor ◽  
Iva Miljkovic ◽  
Andrew R. Hoffman ◽  
...  
2011 ◽  
Vol 59 (7) ◽  
pp. 1217-1224 ◽  
Author(s):  
Christine G. Lee ◽  
Edward J. Boyko ◽  
Elsa S. Strotmeyer ◽  
Cora E. Lewis ◽  
Peggy Mannen Cawthon ◽  
...  

Diagnostics ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 309
Author(s):  
Kun-Yun Yeh ◽  
Hang Huong Ling ◽  
Shu-Hang Ng ◽  
Cheng-Hsu Wang ◽  
Pei-Hung Chang ◽  
...  

Background: This study investigates whether the appendicular skeletal muscle index (ASMI) was an independent prognostic predictor for patients with locally advanced head and neck cancer (LAHNC) receiving concurrent chemoradiotherapy (CCRT) and whether there were any differences in lean mass loss in different body regions during CCRT. Methods: In this prospective study, we analyzed the clinicopathological variables and the total body composition data before and after treatment. The factors associated with the 2-year recurrence-free survival rate (RFSR) were analyzed via logistic regression analysis. Results: A total of 98 patients were eligible for analysis. The body weight, body mass index, and all parameters of body composition significantly decreased after CCRT. The pretreatment ASMI was the only independent prognostic factor for predicting the 2-year RFSR (hazard ratio, 0.235; 95% confidence interval, 0.062–0.885; p = 0.030). There was at least 5% reduction in total lean and fat mass (p < 0.001); however, the highest lean mass loss was observed in the arms (9.5%), followed by the legs (7.2%), hips (7.1%), waist (4.7%), and trunk (3.6%). Conclusions: The pretreatment ASMI was the only independent prognostic predictor for the 2-year RFSR of LAHNC patients undergoing CCRT. Asynchronous loss of lean mass may be observed in different body parts after CCRT.


2020 ◽  
Vol 509 ◽  
pp. 72-78
Author(s):  
Susan H. Gawel ◽  
Gerard J. Davis ◽  
Menghua Luo ◽  
Nicolaas E.P. Deutz ◽  
Robert R. Wolfe ◽  
...  

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Peggy M. Cawthon ◽  
Neeta Parimi ◽  
Lisa Langsetmo ◽  
Jane A. Cauley ◽  
Kristine E. Ensrud ◽  
...  

1996 ◽  
Vol 28 (Supplement) ◽  
pp. 162
Author(s):  
A. D. Ross ◽  
R. A. Wiswell ◽  
S. V. Fortunato ◽  
K. M. Tarpenning ◽  
T. J. Marcell ◽  
...  

2008 ◽  
Vol 108 (7) ◽  
pp. 1216-1220 ◽  
Author(s):  
Melanie J. Bopp ◽  
Denise K. Houston ◽  
Leon Lenchik ◽  
Linda Easter ◽  
Stephen B. Kritchevsky ◽  
...  

2011 ◽  
Vol 1 (9) ◽  
pp. 279
Author(s):  
Sandra Peterson ◽  
Edralin A. Lucas ◽  
Djibril Traore ◽  
Lawrance Christopher ◽  
Christine French ◽  
...  

Background: Exotic mushrooms have long been used in Asia for treatment and/or prevention of chronic diseases due to their immunomodulatory properties. However, the health benefits of portabella mushrooms (PM) (brown Agaricus bisporous), on collagen-induced arthritis (CIA) and associated complications, (i.e. loss of lean mass, increased fat mass and inflammatory cytokines), have not been previously investigated.Methods: We investigated CIA pathogenesis, body composition and plasma levels of IL- 6, TNF-α and sICAM1 in DBA1 female mice fed either the AIN76 diet or the same diet fortified with 5% lyophilized PM (n=19-20/group). Ten mice/group were immunized with 100 µg bovine collagen type II on day 42 of the protocol, followed by 50 µg lipopolysaccharides on day 62, and euthanized on day 73-74. Cytokines were measured by ELISA.Results: Compared to baseline diet, PM had: no protective effect from CIA since all collagen-immunized mice developed severe edema, bone erosion, and mononuclear cell infiltration in paws. In mice with and those without CIA, feeding a PM-fortified diet resulted in higher percent of body fat than feeding the baseline diet (p<0.05). After CIA induction, PM provided the following beneficial effects: (a) a smaller reduction in lean mass and absolute thymus weight; (b) a higher fat mass loss; and (c) lower plasma TNF-α levels (p <0.05). PM-fortification did not alter plasma IL-6 and sICAM1 regardless of CIA status; but it increased in vitro IL-6 secretion by mitogen-treated spleen cells.Conclusion: Our data suggest that PM may reduce plasma TNF-α, attenuate lean mass loss and thymus atrophy associated with arthritis, and protect spleen cell function assessed by IL-6 secretion. However, PM-fortification did not attenuate overall CIA pathogenesis which may be due to lack of effect on plasma IL-6. Decreased TNF-α without alterations in IL-6 may reduce the risk of other conditions associated with chronic inflammation such as cardiovascular disease.Key words: portabella mushrooms, inflammatory cytokines, collagen-induced arthritis, body composition, TNF-α, IL-6, thymus, DBA1 mice.


Sign in / Sign up

Export Citation Format

Share Document